• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】49397

【品名】methyl 4-bromo-3-oxopentanoate

【CA登记号】

【 分 子 式 】C6H9BrO3

【 分 子 量 】209.03966

【元素组成】C 34.47% H 4.34% Br 38.22% O 22.96%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(I)

The cyclization of methyl 4-bromo-3-oxopentanoate (I) with benzamide (II) and sodium hydrogen phosphate in refluxing ethanol gives methyl 2-(5-methyl-2-phenyloxazol-4-yl)acetate (III), which is reduced with LiAlH4 in THF to yield the ethanol derivative (IV). The reaction of (IV) with methanesulfonyl chloride and TEA in dichloromethane affords the mesylate (V), which is condensed with N-(tert-butoxycarbonyl)-L-tyrosine (VI) by means of NaOH in hot DMSO/water to provide the 4-O-substituted tyrosine (VII), which is deprotected by means of HCl in dioxane to give intermediate (VIII) with a free amino group. Finally, this compound is condensed with benzoylacetone (IX) by means of trimethyl orthoformate in refluxing methanol to afford the target N-substituted tyrosine derivative.

1 Oplinger, J.A.; Dezube, M.; Willson, T.M.; Collins, J.L. (Glaxo Group Ltd.); Substd. oxazoles and thiazoles derivs. as hPPAR gamma and hPPAR alpha activators. EP 1102757; WO 0008002 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 49397 methyl 4-bromo-3-oxopentanoate C6H9BrO3 详情 详情
(II) 40592 Benzamide 55-21-0 C7H7NO 详情 详情
(III) 41313 methyl 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)acetate C13H13NO3 详情 详情
(IV) 19874 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-1-ethanol C12H13NO2 详情 详情
(V) 41315 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl methanesulfonate C13H15NO4S 详情 详情
(VI) 25395 (2S)-2-[(tert-butoxycarbonyl)amino]-3-(4-hydroxyphenyl)propionic acid 3978-80-1 C14H19NO5 详情 详情
(VII) 49398 (2S)-2-[(tert-butoxycarbonyl)amino]-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propionic acid C26H30N2O6 详情 详情
(VIII) 49399 (2S)-2-amino-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propionic acid C21H22N2O4 详情 详情
(IX) 23829 1-phenyl-1,3-butanedione 93-91-4 C10H10O2 详情 详情
Extended Information